CalciMedica CALC
NASDAQ CALC
$1.60 -0.05 (-3.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

CalciMedica (CALC) Price to Sales (2024 - 2025)

Updated

CalciMedica's Price to Sales was 269.34 in Q2 2025, up 366.3% from the prior quarter.

Analysis

CalciMedica (CALC) Price to Sales (2024 - 2025) Analysis & Trends

For FY2024, Price to Sales at CalciMedica came in at 47.07.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 CalciMedica 5.64 Mn -12.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 269.34
Mar 31, 2025 57.76
Dec 31, 2024 47.07
API Access

CalciMedica Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=CALC&period=max&api_key=YOUR_API_KEY